Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Standardized Chemical Allergen [EPC]
Fallopia Multiflora Root is a botanical substance classified as a Standardized Chemical Allergen [EPC]. It is primarily utilized in clinical settings for diagnostic allergy testing and has a complex pharmacological profile involving potent bioactive stilbenes and anthraquinones.
Name
Fallopia Multiflora Root
Raw Name
FALLOPIA MULTIFLORA ROOT
Category
Standardized Chemical Allergen [EPC]
Drug Count
4
Variant Count
4
Last Verified
February 17, 2026
About Fallopia Multiflora Root
Fallopia Multiflora Root is a botanical substance classified as a Standardized Chemical Allergen [EPC]. It is primarily utilized in clinical settings for diagnostic allergy testing and has a complex pharmacological profile involving potent bioactive stilbenes and anthraquinones.
Detailed information about Fallopia Multiflora Root
References used for this content
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Fallopia Multiflora Root.
Fallopia Multiflora Root, historically and scientifically known as Polygonum multiflorum and commonly referred to as He Shou Wu, is a complex botanical entity that holds a specific place in modern clinical pharmacology. Within the United States Food and Drug Administration (FDA) classification system, it is categorized as a Standardized Chemical Allergen [EPC], as well as a Non-Standardized Plant Allergenic Extract [EPC] and Non-Standardized Food Allergenic Extract [EPC]. This classification indicates its primary clinical utility in the diagnostic identification of hypersensitivity reactions. While it has a deep history in traditional pharmacopeias, its modern clinical profile is defined by its chemical constituents and their physiological impacts on the human body.
Fallopia Multiflora Root belongs to a class of drugs called Allergenic Extracts. These substances are typically used by healthcare providers to diagnose specific allergies through skin prick testing or intradermal (into the skin) injections. When used as a diagnostic tool, the extract allows clinicians to observe a controlled immune response, which helps in identifying the root cause of a patient's allergic symptoms. Beyond its diagnostic use, the root contains a variety of bioactive compounds, including tetrahydroxystilbene glucoside (TSG), emodin, and physcion, which have been the subject of extensive pharmacological research regarding their effects on the liver, cardiovascular system, and neurological health.
As a Standardized Chemical Allergen, the mechanism of action for Fallopia Multiflora Root in a diagnostic context involves the stimulation of the Type I hypersensitivity pathway. When a small amount of the extract is introduced into the skin, it interacts with IgE (Immunoglobulin E) antibodies bound to the surface of mast cells (immune cells). If the patient is sensitized to the allergens within Fallopia Multiflora, this interaction triggers the degranulation (release) of mast cells, releasing inflammatory mediators such as histamine and leukotrienes. This results in a localized 'wheal and flare' reaction (a raised bump and redness), which the clinician measures to confirm an allergy.
At a molecular level, the non-diagnostic pharmacological effects of Fallopia Multiflora Root are driven by its secondary metabolites. The primary constituent, 2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside (TSG), is believed to mimic some effects of resveratrol, acting as a potent antioxidant. It targets various signaling pathways, including the SIRT1 and NF-κB pathways, which are involved in inflammation and cellular aging. However, it also contains anthraquinones like emodin, which can inhibit certain enzymes such as 11β-HSD1 and interact with hepatic (liver) transport proteins, potentially leading to the hepatotoxicity (liver damage) that is frequently associated with the ingestion of this root.
The pharmacokinetics of Fallopia Multiflora Root are complex due to the presence of multiple active compounds. Most clinical data focuses on the stilbene and anthraquinone components.
The clinical uses of Fallopia Multiflora Root are primarily diagnostic, though it is often discussed in the context of botanical medicine:
Fallopia Multiflora Root is available in several preparations, though the clinical-grade extract is strictly controlled:
> Important: Only your healthcare provider can determine if Fallopia Multiflora Root is right for your specific condition. Diagnostic use should only be performed by a qualified allergist or immunologist.
Dosage for Fallopia Multiflora Root depends entirely on the method of administration and the clinical intent. Because it is primarily a Standardized Chemical Allergen, there is no 'standard' daily dose for health maintenance that is recognized by the FDA.
Fallopia Multiflora Root is generally not recommended for use in children. The risk of hepatotoxicity is significantly higher in pediatric populations due to developing liver enzyme systems. If used for allergy testing in children, it must be performed under the direct supervision of a pediatric allergist, using modified concentrations to minimize the risk of systemic reactions.
There are no specific guidelines for dosage adjustment in patients with renal (kidney) impairment for diagnostic testing. However, for oral consumption, reduced clearance of metabolites may increase the risk of systemic toxicity.
Fallopia Multiflora Root is strictly contraindicated in patients with any form of hepatic (liver) impairment. The root is known to cause idiosyncratic (unpredictable) liver injury, and pre-existing liver disease significantly increases the risk of liver failure.
Geriatric patients should be monitored closely during diagnostic testing for cardiovascular stability. For oral use, the elderly are at a higher risk for adverse drug-herb interactions and age-related liver sensitivity.
Instructions for administration vary by form:
In the context of diagnostic testing, a missed appointment should be rescheduled as soon as possible. For those taking oral supplements under medical supervision, a missed dose should be taken as soon as remembered, unless it is nearly time for the next dose. Do not double the dose to catch up.
Signs of an overdose of Fallopia Multiflora Root (particularly oral ingestion) include:
In the event of an overdose, immediate medical attention is required. There is no specific antidote; treatment is supportive and focuses on maintaining liver function and managing symptoms.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose or start taking this substance without medical guidance, especially given its high risk-to-benefit ratio.
When used as a diagnostic allergen, the most common side effects are localized to the site of administration:
> Warning: Stop taking Fallopia Multiflora Root and call your doctor immediately if you experience any of these serious symptoms.
Prolonged use of Fallopia Multiflora Root is associated with several chronic risks:
No FDA black box warnings currently exist for Fallopia Multiflora Root when used as a standardized allergen extract. However, several international regulatory agencies (such as the UK's MHRA and China's NMPA) have issued high-level safety alerts regarding its potential for severe liver injury. Healthcare providers are advised to monitor liver enzymes (ALT, AST, Bilirubin) in any patient using this substance orally.
Report any unusual symptoms to your healthcare provider immediately. Adverse events should also be reported to the FDA's MedWatch program.
Fallopia Multiflora Root is a potent biological substance. Its use in diagnostic allergy testing must be conducted by trained professionals. For those considering its use as a botanical supplement, the risk of severe liver injury is a primary concern. It is not a 'gentle' herb; it contains active chemicals that can significantly alter human physiology.
No FDA black box warnings for Fallopia Multiflora Root. However, clinicians should treat the risk of hepatotoxicity with the same level of caution as a black box warning. In 2014, the China Food and Drug Administration (CFDA) specifically restricted its use and mandated liver function monitoring for all patients.
If a healthcare provider prescribes or monitors the use of Fallopia Multiflora Root, the following tests are essential:
In most cases, Fallopia Multiflora Root does not impair the ability to drive. However, if a patient experiences dizziness or a systemic reaction during allergy testing, they should not operate machinery until the symptoms have completely resolved and they have been cleared by a clinician.
Alcohol should be strictly avoided. Alcohol consumption increases the metabolic load on the liver and can synergistically increase the risk of hepatotoxicity when combined with Fallopia Multiflora Root.
For diagnostic use, there is no withdrawal syndrome. For oral use, the substance should be discontinued immediately if any signs of liver dysfunction appear. There is no requirement for tapering, but patients should be monitored for several weeks post-discontinuation to ensure liver enzymes return to baseline.
> Important: Discuss all your medical conditions, especially liver or kidney issues, with your healthcare provider before starting Fallopia Multiflora Root.
For each major interaction, the management strategy involves either avoiding the combination entirely or performing frequent laboratory monitoring to ensure patient safety.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, including over-the-counter drugs.
Fallopia Multiflora Root must NEVER be used in the following circumstances:
Conditions requiring a careful risk-benefit analysis by a physician:
Patients allergic to Fallopia Multiflora Root may also react to:
> Important: Your healthcare provider will evaluate your complete medical history, including any history of jaundice or allergies, before prescribing or using Fallopia Multiflora Root.
Fallopia Multiflora Root is classified as Category X in many traditional systems and should be avoided during pregnancy. The anthraquinones (like emodin) can stimulate uterine contractions, potentially leading to miscarriage or preterm labor. Furthermore, the risk of maternal hepatotoxicity poses a direct threat to fetal viability. There is no established safe dose for pregnant women.
It is unknown if all constituents of Fallopia Multiflora Root pass into breast milk; however, anthraquinones are known to pass into milk and can cause diarrhea in the nursing infant. Due to the potential for serious adverse reactions, breastfeeding is not recommended while using this substance.
Fallopia Multiflora Root is not approved for general use in children. In the context of allergy testing, it should only be used if the diagnostic necessity outweighs the risks and must be performed by a specialist. Children are particularly vulnerable to the toxic effects of anthraquinones on the developing gut and liver.
Elderly patients are at a higher risk for adverse effects. Age-related declines in hepatic and renal function mean that the active compounds may stay in the system longer. There is also an increased risk of falls if the substance causes significant diarrhea or dizziness. Polypharmacy (taking multiple medications) in the elderly also makes drug-herb interactions much more likely.
In patients with a GFR below 60 mL/min/1.73m², Fallopia Multiflora Root should be used with extreme caution. While the primary toxicity is hepatic, the kidneys are responsible for excreting the glucuronide conjugates of its metabolites. Impaired clearance can lead to systemic accumulation.
Hepatic impairment is a strict contraindication. According to the Child-Pugh classification, even patients with Class A (mild) impairment should avoid this substance, as it can trigger a rapid progression to liver failure.
> Important: Special populations require individualized medical assessment and often require safer alternatives for both diagnosis and treatment.
Fallopia Multiflora Root acts through multiple pathways. As an Allergenic Extract, it triggers IgE-mediated mast cell degranulation upon contact with the immune system of a sensitized individual.
Pharmacologically, its most studied component, 2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside (TSG), acts as an antioxidant by scavenging free radicals and upregulating antioxidant enzymes like superoxide dismutase (SOD). It also interacts with the SIRT1 (Sirtuin 1) protein, which is involved in DNA repair and cellular longevity. However, the anthraquinone components (emodin, physcion) act as ligands for the Aryl Hydrocarbon Receptor (AhR) and can inhibit the activity of UDP-glucuronosyltransferases (UGTs), which is the proposed mechanism for its liver toxicity.
The dose-response relationship for Fallopia Multiflora is highly variable. In allergy testing, the onset of the 'wheal and flare' reaction is rapid, typically peaking at 15-20 minutes. The duration of the localized skin reaction is usually 2 to 4 hours. When taken orally, the laxative effects typically occur within 6 to 12 hours of ingestion.
| Parameter | Value |
|---|---|
| Bioavailability | <20% (for TSG) |
| Protein Binding | 85-95% |
| Half-life | 2-4 hours (TSG); 24+ hours (Emodin) |
| Tmax | 0.5 - 2 hours |
| Metabolism | Hepatic (CYP1A2, CYP2E1, UGT1A1) |
| Excretion | Renal 40%, Fecal 60% |
Fallopia Multiflora Root is classified as a Standardized Chemical Allergen. It is related to other plant-based allergenic extracts used in diagnostic medicine, such as Ambrosia (Ragweed) or Dermatophagoides (Dust Mite) extracts, though its chemical profile is significantly more complex due to its secondary metabolite content.
Common questions about Fallopia Multiflora Root
In clinical medicine, Fallopia Multiflora Root is primarily used as a standardized allergenic extract for diagnostic allergy testing. It helps healthcare providers identify if a patient has a specific IgE-mediated hypersensitivity to this plant or its components. Outside of the clinical diagnostic setting, it is often found in traditional botanical preparations intended for hair health and vitality. However, these traditional uses are not FDA-approved and carry significant risks. Always consult a doctor before using it for any purpose other than professional diagnostic testing.
The most common side effects depend on how the root is used. During diagnostic skin testing, patients typically experience localized itching, redness, and a small raised bump (wheal) at the site of the test. If taken orally as a supplement, common side effects include gastrointestinal issues such as diarrhea, abdominal cramps, and nausea. More seriously, it is well-documented to cause liver inflammation in some users. If you notice yellowing of the skin or eyes, you must seek medical help immediately.
No, you should not consume alcohol while taking Fallopia Multiflora Root. Both alcohol and the active compounds in the root (specifically anthraquinones) are processed by the liver. Combining them significantly increases the metabolic strain on the liver and raises the risk of drug-induced liver injury (DILI). Even moderate alcohol consumption can exacerbate the hepatotoxic effects of the root. Safety is the priority, so it is best to avoid alcohol entirely if you are using this substance.
Fallopia Multiflora Root is considered unsafe during pregnancy and should be avoided. It contains anthraquinones, which are compounds that can stimulate uterine contractions and potentially lead to miscarriage or premature labor. Additionally, the risk of liver toxicity is a major concern for both the mother and the developing fetus. There is insufficient evidence to establish any safe level of use during pregnancy. Pregnant women should always consult their obstetrician before taking any herbal or botanical product.
In a diagnostic setting, such as a skin prick test, the reaction is very fast, usually appearing within 15 to 20 minutes. This allows the allergist to provide immediate results regarding a potential allergy. For its traditional oral uses, such as hair health, proponents claim it takes 3 to 6 months of consistent use to see results. However, medical professionals warn against long-term use due to the cumulative risk of liver damage. Because of these risks, 'waiting for it to work' can be dangerous without medical supervision.
Yes, you can stop taking Fallopia Multiflora Root suddenly, as it does not cause physiological dependence or a withdrawal syndrome. In fact, if you experience any signs of liver trouble, such as dark urine or upper stomach pain, you should stop taking it immediately. Discontinuing the product is the first step in managing any adverse reactions. After stopping, you should notify your healthcare provider so they can monitor your liver enzymes. There is no need to taper the dose.
If you are taking Fallopia Multiflora Root under the guidance of a healthcare provider and miss a dose, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and continue with your regular schedule. Never take two doses at once to make up for a missed one, as this increases the risk of toxic effects on the liver. If the root was being used for a diagnostic test, simply reschedule the appointment with your doctor. Consistency is less important than safety when dealing with this specific substance.
There is no clinical evidence to suggest that Fallopia Multiflora Root causes weight gain. In fact, due to its anthraquinone content, which acts as a stimulant laxative, some people may experience temporary weight loss due to fluid loss and increased bowel movements. However, this is not a healthy or recommended way to manage weight. If you notice unusual weight changes or swelling (edema) while taking this product, it could indicate a more serious underlying issue like liver or kidney distress. You should discuss any weight changes with your doctor.
Fallopia Multiflora Root has many significant drug interactions and should be used with extreme caution alongside other medications. It is particularly dangerous when combined with other drugs that can affect the liver, such as acetaminophen or certain cholesterol medications. It can also interact with blood thinners like warfarin, increasing the risk of bleeding. Because it can lower potassium levels, it may also make heart medications like digoxin more toxic. Always provide your doctor with a full list of your current medications before starting this root.
Fallopia Multiflora Root is a botanical substance, so the concept of 'generic' vs. 'brand name' is slightly different than with synthetic drugs. It is available from many different manufacturers as a dietary supplement under names like He Shou Wu or Fo-Ti. However, in the clinical diagnostic world, it is sold as a 'Standardized Allergenic Extract' by specialized pharmaceutical companies. These clinical versions are highly purified and regulated. When buying supplements, be aware that quality and concentration can vary wildly between brands, which increases the risk of contamination or toxicity.